Delivery Order SPE2DE24DA017-SPE2D625F0DDL
- Not listed
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $3,029.40 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the ACP MAX PRP System with ACDA. The delivery order, which is not set-aside for any specific business category, has an ultimate completion date of July 29, 2025, and will be performed in Naples, Florida. This award represents a task order under Arthrex's broader Indefinite...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $5,775 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of July 28, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies based in Naples, Florida, received a delivery order valued at $6,586.92 from the Defense Logistics Agency's Medical Supply Chain on August 5, 2025. This fixed-price delivery order with economic price adjustment, designated as IMPL SYS, MPFL, FASTTHREAD, represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and...
- Arthrex Inc., a leading developer of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a fixed-price delivery order valued at $25,122.10 by the Defense Logistics Agency's Medical Supply Chain. The contract, awarded on July 23, 2025, with an ultimate completion date of July 28, 2025, calls for the delivery of an ACD-A 13G Open Tip BMA Angel Kit—a specialized orthopedic surgical product related to Arthrex's ANGEL platelet-rich plasma (PRP) system. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $3,577.20 from the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, with an ultimate completion date of August 6, 2025. The delivery order covers the Arthrex ANGEL PRP Kit for the U.S. market, a specialized medical device used in orthopedic procedures. This award was not set aside for any specific business category, reflecting...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $1,376.10 for an ACP Kit Series II from the Defense Logistics Agency's Medical Supply Chain on August 8, 2025. This fixed-price delivery order with economic price adjustment reflects a task order under Arthrex's significant Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and extending through September...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,024.90 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 12, 2025. This fixed-price contract with economic price adjustment is a delivery order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running...
- Arthrex Inc., a leading global orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $8,664.00 fixed-price delivery order for the ARTHREX ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. The delivery order, which carries an ultimate completion date of July 28, 2025, represents a task order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) valued at $471,048,172.66 and running through...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order valued at $39,164.85 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is set to conclude by August 7, 2025, and covers the supply of a kinematic-less T-rope with drive system utilizing synthetic replication technology. The work will be performed in Naples, Florida....
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F0DDLDelivery Order
Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $52,879.14 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for an ACP MAX PRP System with ACDA technology. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. Performance is scheduled to conclude by August 7, 2025, with the work to be performed at Arthrex's Naples, Florida location. The ACP MAX PRP System delivery supports the Department of Defense's healthcare supply chain requirements for advanced orthopedic surgical solutions. Arthrex has established itself as a primary provider of minimally invasive orthopedic technologies to federal healthcare systems, particularly serving the Department of Defense and Department of Veterans Affairs through its comprehensive IDC. This delivery order exemplifies the company's ongoing role in supplying specialized surgical implants and arthroscopic instruments to government healthcare facilities nationwide, with the fixed-price structure including economic price adjustment provisions to address potential cost fluctuations during the brief performance period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.9k | 8/4/25 |